GB0705803D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0705803D0 GB0705803D0 GBGB0705803.5A GB0705803A GB0705803D0 GB 0705803 D0 GB0705803 D0 GB 0705803D0 GB 0705803 A GB0705803 A GB 0705803A GB 0705803 D0 GB0705803 D0 GB 0705803D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0705803.5A GB0705803D0 (en) | 2007-03-28 | 2007-03-28 | Novel compounds |
PCT/EP2008/053354 WO2008116816A1 (en) | 2007-03-26 | 2008-03-20 | Combination of cb2 ligand and paracetamol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0705803.5A GB0705803D0 (en) | 2007-03-28 | 2007-03-28 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0705803D0 true GB0705803D0 (en) | 2007-05-02 |
Family
ID=38024883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0705803.5A Ceased GB0705803D0 (en) | 2007-03-26 | 2007-03-28 | Novel compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0705803D0 (en) |
WO (1) | WO2008116816A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1392679B1 (en) * | 2001-05-10 | 2005-11-02 | Solvay Pharmaceuticals GmbH | Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds |
WO2009124553A2 (en) * | 2008-04-09 | 2009-10-15 | Neurokey A/S | Use of hypothermia inducing drugs |
CN102378757A (en) | 2009-03-30 | 2012-03-14 | 安斯泰来制药株式会社 | Pyrimidine compound |
TWI482622B (en) * | 2010-07-29 | 2015-05-01 | Astellas Pharma Inc | Shrinkage pyridine compounds |
PL3027600T3 (en) * | 2013-07-31 | 2022-08-08 | Novartis Ag | 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions |
JP7212781B2 (en) | 2018-12-19 | 2023-01-25 | ディスアーム セラピューティクス, インコーポレイテッド | Inhibitors of SARM1 in combination with neuroprotective agents |
CN111777593B (en) * | 2019-04-03 | 2024-07-23 | 南京天印健华医药科技有限公司 | Novel compounds as inhibitors of rearrangement kinase during transfection |
CN112661688B (en) * | 2019-10-16 | 2023-04-07 | 杭州迪克科技有限公司 | Synthetic method of non-steroidal anti-inflammatory drug tolmetin |
CN115282279B (en) * | 2022-08-08 | 2024-03-12 | 暨南大学附属第一医院(广州华侨医院) | Application of CNR2 as sepsis acute lung injury treatment target through mediating DCs maturation and function |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY27939A1 (en) * | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | COMPOUNDS |
GB0402355D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
CA2569887A1 (en) * | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
JP2009504587A (en) * | 2005-08-09 | 2009-02-05 | グラクソ グループ リミテッド | Imidazopyridine derivatives as nannabinoid receptor ligands |
-
2007
- 2007-03-28 GB GBGB0705803.5A patent/GB0705803D0/en not_active Ceased
-
2008
- 2008-03-20 WO PCT/EP2008/053354 patent/WO2008116816A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008116816A1 (en) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0710528D0 (en) | Novel compounds | |
EP2152081A4 (en) | Novel compounds | |
GB0712888D0 (en) | Novel compounds | |
EP2146745A4 (en) | Novel compounds | |
GB0705882D0 (en) | Novel compounds | |
GB0710865D0 (en) | Novel compounds | |
GB0706630D0 (en) | Novel compounds | |
GB0705803D0 (en) | Novel compounds | |
GB0708858D0 (en) | Novel compounds | |
GB0710863D0 (en) | Novel compounds | |
GB0711521D0 (en) | Novel compounds | |
GB0712392D0 (en) | Novel compounds | |
GB0703973D0 (en) | Novel compounds | |
GB0703402D0 (en) | Novel compounds | |
GB0708222D0 (en) | Novel compounds | |
GB0703631D0 (en) | Novel compounds | |
GB0703677D0 (en) | Novel compounds | |
GB0703404D0 (en) | Novel compounds | |
GB0704012D0 (en) | Novel compounds | |
GB0704088D0 (en) | Novel compounds | |
GB0704324D0 (en) | Novel compounds | |
GB0704766D0 (en) | Novel compounds | |
GB0705263D0 (en) | Novel compounds | |
GB0703397D0 (en) | Novel compounds | |
GB0703387D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |